Difference between revisions of "Contexts"
Jump to navigation
Jump to search
(Created page with "''The purpose of this page is to define treatment contexts used in the HemOnc ontology; it is not for other purposes at this time.'' =FDA indication language= ==Metastatic==...") |
m |
||
| (5 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
=FDA indication language= | =FDA indication language= | ||
| + | ==Early stage== | ||
| + | ==Locally advanced== | ||
| + | ==Advanced== | ||
| + | ==Advanced or metastatic== | ||
==Metastatic== | ==Metastatic== | ||
==Relapsed or refractory== | ==Relapsed or refractory== | ||
==Untreated== | ==Untreated== | ||
| + | AKA: Newly diagnosed | ||
| + | |||
=Treatment contexts= | =Treatment contexts= | ||
| + | ==Remission induction== | ||
| + | ==Maintenance== | ||
| + | ==First-line therapy== | ||
| + | ==Second-line therapy== | ||
| + | ==Third-line therapy== | ||
| + | ==Subsequent-line therapy== | ||
[[Category:Ontology pages]] | [[Category:Ontology pages]] | ||
Latest revision as of 01:45, 12 April 2021
The purpose of this page is to define treatment contexts used in the HemOnc ontology; it is not for other purposes at this time.
FDA indication language
Early stage
Locally advanced
Advanced
Advanced or metastatic
Metastatic
Relapsed or refractory
Untreated
AKA: Newly diagnosed